Actively hiring
Drug Discovery
Biotechnology
Follow
Overview
News
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Backers
1
Partners for Growth
Momentum
0/100
no fresh signals
Last sign of life
this month
a posting or a news item
Registers and programsofficial lists and records that name the company
| Legal entity | Pty Ltd | its site |
Backed byfrom the funds' portfolios and accelerator catalogs
Investors in similar startupsfunds that back the companies most like this one
backs Alloy Therapeutics

backs Terray Therapeutics

backs Khumbu.ai

backs FluoSphera SA

backs MOLCURE
Similar startupsby what they do, their industry and backers

Light Horse is a small molecule drug discovery company that is leading the way in a.

The only integrated full-stack AI platform for small molecule drug discovery.

Metanova Labs is an AI drug discovery company building a new model for discovering and developing novel therapeutics. Through NOVA, its…

Alloy Therapeutics democratizes access to antibody discovery and biologics discovery technology to enable and advance drug discovery in…

Molcure Inc. is an AI company focusing on accelerating drug discovery through the combination machine learning, biotechnology, and robotics.

Advanced 3D and multi-tissue biology for predictive drug discovery. Ready-to-use microtissues for efficacy, safety, DMPK-Tox & biomarker…
News
Viva Biotech's 2023 Overseas Appreciation Receptions Prove to be a Great Success Again
Viva Biotech's 2023 Overseas Appreciation Receptions Prove to be a Great Success Again #generic_content-block_7fcac4113c5f4bc369ec69d9eb20e1ea { padding-top: 30px; padding-bottom: 30px; } @media (max-width: 818px) and (min-width: 0px) { #generic_content-b
Read more
Report
SYNthesis med chem, Cytopia and Ojjaara
SYNthesis med chem, Cytopia and Ojjaara #generic_content-block_52a10da861b0e6a66a1c15202df0b4dc { padding-top: 30px; padding-bottom: 30px; } @media (max-width: 818px) and (min-width: 0px) { #generic_content-block_52a10da861b0e6a66a1c15202df0b4dc { padding
Read more
Report
SYNthesis med chem supporting a variety of Drug Discovery events through the end of 2023 and into 2024
SYNthesis med chem supporting a variety of Drug Discovery events through the end of 2023 and into 2024 #generic_content-block_c6249dcb1c404794d98b2076e2ac2413 { padding-top: 30px; padding-bottom: 30px; } @media (max-width: 818px) and (min-width: 0px) { #g
Read more
Report
SYNthesis med chem, Viva Biotech providing innovation and support to Targeted Protein Degradation (TPD) Drug Discovery projects
SYNthesis med chem, Viva Biotech providing innovation and support to Targeted Protein Degradation (TPD) Drug Discovery projects #generic_content-block_869cd23acd64c642daada374161eea17 { padding-top: 30px; padding-bottom: 30px; } @media (max-width: 818px)
Read more
Report
SYNthesis med chem joins Lean Life Science's Oncology Development Programme (ODP2)
SYNthesis med chem joins Lean Life Science's Oncology Development Programme (ODP2) #generic_content-block_390382597e16e5e093ffce66651d5401 { padding-top: 30px; padding-bottom: 30px; } @media (max-width: 818px) and (min-width: 0px) { #generic_content-block
Read more
Report

Partners for Growth 